The European Medicines Agency is recommending that pioglitazone-containing medicines for diabetes, including Actos, carry a warning of a small increased risk of bladder cancer. However it said the benefit-risk of the drugs remains positive. ---Subscribe to MedNous to access this article--- Regulation & Policy
